These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 26301462

  • 1. Pharmacological Evidence that Histamine H3 Receptors Mediate Histamine-Induced Inhibition of the Vagal Bradycardic Out-flow in Pithed Rats.
    García M, García-Pedraza JÁ, Villalón CM, Morán A.
    Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):113-21. PubMed ID: 26301462
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological evidence that histamine H3 receptors inhibit the vasodepressor responses by selective stimulation of the rat perivascular sensory CGRPergic outflow.
    Manrique-Maldonado G, Altamirano-Espinoza AH, Marichal-Cancino BA, Rivera-Mancilla E, Avilés-Rosas V, Villalón CM.
    Eur J Pharmacol; 2015 May 05; 754():25-31. PubMed ID: 25704614
    [Abstract] [Full Text] [Related]

  • 3. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow.
    Pinacho-García M, Marichal-Cancino BA, Villalón CM.
    Eur J Pharmacol; 2016 Feb 15; 773():85-92. PubMed ID: 26826593
    [Abstract] [Full Text] [Related]

  • 4. The role of pre-junctional D2 -like receptors mediating quinpirole-induced inhibition of the vasodepressor sensory CGRPergic out-flow in pithed rats.
    Manrique-Maldonado G, González-Hernández A, Altamirano-Espinoza AH, Marichal-Cancino BA, Ruiz-Salinas I, Villalón CM.
    Basic Clin Pharmacol Toxicol; 2014 Feb 15; 114(2):174-80. PubMed ID: 23964609
    [Abstract] [Full Text] [Related]

  • 5. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
    García M, Morán A, Martín ML, Ortizde Urbina AV, San Román L.
    Clin Exp Pharmacol Physiol; 2007 Nov 15; 34(11):1199-206. PubMed ID: 17880377
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats.
    Godlewski G, Malinowska B, Buczko W, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb 15; 355(2):261-6. PubMed ID: 9050021
    [Abstract] [Full Text] [Related]

  • 7. Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia.
    García-Pedraza JÁ, García M, Martín ML, Eleno N, Morán A.
    J Cardiovasc Pharmacol; 2017 Jan 15; 69(1):13-22. PubMed ID: 27676327
    [Abstract] [Full Text] [Related]

  • 8. Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats.
    González-Hernández A, Muñoz-Islas E, Lozano-Cuenca J, Ramírez-Rosas MB, Sánchez-López A, Centurión D, Ramírez-San Juan E, Villalón CM.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):131-7. PubMed ID: 20385119
    [Abstract] [Full Text] [Related]

  • 9. Fluoxetine oral treatment discloses 5-HT1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat.
    López C, Gómez-Roso M, García-Pedraza JÁ, Martín ML, Morán A, García-Domingo M.
    Can J Physiol Pharmacol; 2019 Feb 10; 97(2):90-98. PubMed ID: 30462556
    [Abstract] [Full Text] [Related]

  • 10. Differential cardiac sympatho-inhibitory responses produced by the agonists B-HT 933, quinpirole and immepip in normoglycaemic and diabetic pithed rats.
    Rivera-Mancilla E, Altamirano-Espinoza AH, Manrique-Maldonado G, Villanueva-Castillo B, Villalón CM.
    Clin Exp Pharmacol Physiol; 2018 Aug 10; 45(8):767-778. PubMed ID: 29675928
    [Abstract] [Full Text] [Related]

  • 11. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
    Marichal-Cancino BA, Altamirano-Espinoza AH, Manrique-Maldonado G, MaassenVanDenBrink A, Villalón CM.
    Basic Clin Pharmacol Toxicol; 2014 Mar 10; 114(3):240-7. PubMed ID: 24118786
    [Abstract] [Full Text] [Related]

  • 12. The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type.
    Manrique-Maldonado G, González-Hernández A, Marichal-Cancino BA, Villamil-Hernández MT, del Mercado OA, Centurión D, Villalón CM.
    Basic Clin Pharmacol Toxicol; 2011 Dec 10; 109(6):506-12. PubMed ID: 21740529
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats.
    Rubio-Beltrán E, Labastida-Ramírez A, Hernández-Abreu O, MaassenVanDenBrink A, Villalón CM.
    Eur J Pharmacol; 2017 Oct 05; 812():97-103. PubMed ID: 28694067
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge.
    García-Pedraza JÁ, Morán A, Martín ML, Ollauri-Ibáñez C, Rodríguez-Barbero A, Villalón CM, García-Domingo M.
    Pflugers Arch; 2020 Dec 05; 472(12):1693-1703. PubMed ID: 32820344
    [Abstract] [Full Text] [Related]

  • 15. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.
    González-Hernández A, Lozano-Cuenca J, Marichal-Cancino BA, MaassenVanDenBrink A, Villalón CM.
    J Headache Pain; 2018 May 25; 19(1):40. PubMed ID: 29802544
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL, Rizzo CA, West RE, Aslanian R, McCormick K, Bryant M, Hsieh Y, Korfmacher W, Mingo GG, Varty L, Williams SM, Shih NY, Egan RW, Hey JA.
    J Pharmacol Exp Ther; 2003 Jun 25; 305(3):1037-44. PubMed ID: 12649305
    [Abstract] [Full Text] [Related]

  • 17. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
    González-Hernández A, Manrique-Maldonado G, Lozano-Cuenca J, Muñoz-Islas E, Centurión D, Maassen VanDenBrink A, Villalón CM.
    Eur J Pharmacol; 2011 Jun 01; 659(2-3):233-43. PubMed ID: 21473863
    [Abstract] [Full Text] [Related]

  • 18. Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.
    Avilés-Rosas VH, Rivera-Mancilla E, Marichal-Cancino BA, Manrique-Maldonado G, Altamirano-Espinoza AH, Maassen Van Den Brink A, Villalón CM.
    Br J Pharmacol; 2017 Jul 01; 174(13):2001-2014. PubMed ID: 28369749
    [Abstract] [Full Text] [Related]

  • 19. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
    Sadek B, Saad A, Subramanian D, Shafiullah M, Łażewska D, Kieć-Kononowiczc K.
    Neuropharmacology; 2016 Jul 01; 106():46-55. PubMed ID: 26525191
    [Abstract] [Full Text] [Related]

  • 20. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA, Aslanian R, Bolser DC, Chapman RW, Egan RW, Rizzo CA, Shih NY, Fernandez X, McLeod RL, West R, Kreutner W.
    Arzneimittelforschung; 1998 Sep 01; 48(9):881-8. PubMed ID: 9793613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.